Grainne Quinn Perrigo CO PLC (PRGO) insider trading activity

Grainne Quinn is EVP, Chief Medical Officer of PERRIGO Co plc. Currently has a direct ownership of 21,078 shares of PRGO, which is worth approximately $600,301. The most recent transaction as insider was on Mar 07, 2024, when has been sold 1,170 shares (Ordinary Shares) at a price of $29.69 per share, resulting in proceeds of $34,737. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.1K

0% 3M change

49.88% 12M change

Total Value Held $600,301

Grainne Quinn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2024	SELL Payment of exercise price or tax liability	$34,737 $29.69 p/Share	1,170 Reduced 5.26%	21,078 Ordinary Shares
Mar 07 2024	BUY Exercise of conversion of derivative security	$66,772 $29.69 p/Share	2,249 Added 9.18%	22,248 Ordinary Shares
Mar 06 2024	SELL Payment of exercise price or tax liability	$25,702 $28.09 p/Share	915 Reduced 4.38%	19,999 Ordinary Shares
Mar 06 2024	BUY Exercise of conversion of derivative security	$49,410 $28.09 p/Share	1,759 Added 7.76%	20,914 Ordinary Shares
Mar 05 2024	SELL Payment of exercise price or tax liability	$150,447 $27.26 p/Share	5,519 Reduced 22.37%	19,155 Ordinary Shares
Mar 05 2024	BUY Grant, award, or other acquisition	$246,103 $27.26 p/Share	9,028 Added 27.46%	23,850 Ordinary Shares
Mar 05 2024	BUY Exercise of conversion of derivative security	$43,152 $27.26 p/Share	1,583 Added 9.19%	15,646 Ordinary Shares
Mar 07 2023	SELL Payment of exercise price or tax liability	$44,120 $37.71 p/Share	1,170 Reduced 7.68%	14,063 Ordinary Shares
Mar 07 2023	BUY Exercise of conversion of derivative security	$84,847 $37.71 p/Share	2,250 Added 12.87%	15,233 Ordinary Shares
Mar 03 2023	SELL Payment of exercise price or tax liability	$162,362 $38.75 p/Share	4,190 Reduced 24.4%	12,983 Ordinary Shares
Mar 03 2023	BUY Exercise of conversion of derivative security	$102,145 $38.75 p/Share	2,636 Added 16.03%	13,807 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	$209,986 $38.75 p/Share	5,419 Added 27.15%	14,537 Ordinary Shares
Dec 16 2022	SELL Open market or private sale	$74,947 $31.65 p/Share	2,368 Reduced 20.62%	9,118 Ordinary Shares
Mar 04 2022	SELL Payment of exercise price or tax liability	$191,176 $37.23 p/Share	5,135 Reduced 30.89%	11,486 Ordinary Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	$143,782 $37.23 p/Share	3,862 Added 23.88%	12,310 Ordinary Shares
Mar 04 2022	BUY Grant, award, or other acquisition	$223,678 $37.23 p/Share	6,008 Added 32.01%	12,759 Ordinary Shares
Mar 08 2021	SELL Payment of exercise price or tax liability	$45,291 $41.82 p/Share	1,083 Reduced 16.07%	5,658 Ordinary Shares
Mar 08 2021	BUY Grant, award, or other acquisition	$87,069 $41.82 p/Share	2,082 Added 23.6%	6,741 Ordinary Shares
Mar 05 2021	SELL Payment of exercise price or tax liability	$48,673 $41.04 p/Share	1,186 Reduced 14.94%	6,751 Ordinary Shares
Mar 05 2021	BUY Exercise of conversion of derivative security	$93,530 $41.04 p/Share	2,279 Added 23.79%	7,299 Ordinary Shares

Grainne Quinn

EVP, Chief Medical Officer

Allegan, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRGO shares.

Notify only if

Value

Insider Trading

Get notified when an Perrigo CO PLC insider buys or sells PRGO shares.

Notify only if

Operation

Value

Type

News

Receive news related to PERRIGO Co plc

Track Activities on PRGO

Account